CSIMarket


Harvard Bioscience Inc  (HBIO)
Other Ticker:  
 

Harvard Bioscience Inc

HBIO's Fundamental analysis








Looking into Harvard Bioscience Inc growth rates, revenue grew by 0.95 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 1419

Laboratory Analytical Instruments industry recorded deterioration of revenues by -6.08 %



More on HBIO's Growth


Harvard Bioscience Inc
realized net loss in trailing twelve months.

Harvard Bioscience Inc realized cash outflow of $ -0.01per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.56.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.16.


More on HBIO's Valuation
 
 Total Debt (Millions $) 37
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 387,789
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.82
 Tangible Book Value (Per Share $) 0.00

Harvard Bioscience Inc
realized net loss in trailing twelve months.

Harvard Bioscience Inc realized cash outflow of $ -0.01per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.56.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.16.

Harvard Bioscience Inc Price to Book Ratio is at 2.39 lower than Indusry Avg. of 247.11. and higher than S&P 500 Avg. of 0.01

More on HBIO's Valuation

  Market Capitalization (Millions $) 175
  Shares Outstanding (Millions) 43
  Employees 289
  Revenues (TTM) (Millions $) 112
  Net Income (TTM) (Millions $) -3
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -2
  Total Debt (Millions $) 37
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 387,789
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.82
  Tangible Book Value (Per Share $) 0.00

  Market Capitalization (Millions $) 175
  Shares Outstanding (Millions) 43
  Employees 289
  Revenues (TTM) (Millions $) 112
  Net Income (TTM) (Millions $) -3
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -2


    HBIO's Profitability Comparisons
Harvard Bioscience Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 13.17 %.







  Ratio
   Capital Ratio (MRQ) 1.85
  Total Debt to Equity (MRQ) 0.5
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.81
  Inventory Turnover Ratio (TTM) 1.78



Harvard Bioscience Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 13.17 %.



More on HBIO's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com